Suppr超能文献

数字工具、多学科和创新在 COVID-19 时代用于传播疫苗安全信息。

Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era.

机构信息

Multifactorial and Complex Diseases Research Area, Bambino Gesù Children's Hospital, Rome, Italy.

Immunize Canada, Canadian Public Health Association, Ottawa, Canada.

出版信息

Hum Vaccin Immunother. 2022 Dec 31;18(1):1865048. doi: 10.1080/21645515.2020.1865048. Epub 2021 Mar 25.

Abstract

The research on the anti-SARS-CoV-2 vaccines and their commercialization is an opportunity to test and consolidate the current knowledge along with the diverse available tools related to vaccine communication.In this paper we explore the value of a multidisciplinary approach in this field: vaccine communication activities can be combined with insights from data science, risk communication, behavior change, design thinking and digital marketing. Methodologies derived from innovation and human-centered design can contribute to the development and testing of vaccine promotion campaigns, speeding up processes and streamlining the production of evidence in this area. The multiple activities involving the anti-SARS-CoV-2 vaccine could be the fertile ground in which to develop, test and refine effective frameworks to transfer data acquired through listening strategies into effective vaccine promotion campaigns. The World Health Organization's Vaccine Safety Net is an interesting example of trusted information sources that aim toward using digital tools and innovative methodologies for communicating science-based information on vaccine safety at the global level.

摘要

抗 SARS-CoV-2 疫苗的研究及其商业化是一个检验和巩固当前知识的机会,同时也可以利用与疫苗传播相关的多样化现有工具。本文探讨了在这一领域采用多学科方法的价值:疫苗传播活动可以结合数据科学、风险传播、行为改变、设计思维和数字营销方面的见解。创新和以人为中心的设计方法学可以为疫苗推广活动的开发和测试做出贡献,从而加快这一领域的进程并简化证据的产生。涉及抗 SARS-CoV-2 疫苗的多项活动可能是一个有利的领域,可以在此开发、测试和完善有效的框架,将通过倾听策略获得的数据转化为有效的疫苗推广活动。世界卫生组织的疫苗安全网是一个有趣的例子,它是一个值得信赖的信息来源,旨在利用数字工具和创新方法在全球范围内传播基于科学的疫苗安全信息。

相似文献

2
Vaccine safety - is the SARS-CoV-2 vaccine any different?疫苗安全性 - SARS-CoV-2 疫苗有何不同?
Hum Vaccin Immunother. 2021 May 4;17(5):1322-1325. doi: 10.1080/21645515.2020.1829414. Epub 2020 Dec 3.
4
Assessing the Safety of COVID-19 Vaccines: A Primer.评估 COVID-19 疫苗的安全性:入门介绍。
Drug Saf. 2020 Dec;43(12):1205-1210. doi: 10.1007/s40264-020-01002-6. Epub 2020 Sep 30.
7
COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety.COVID-19 疫苗犹豫:疫苗安全性的错误信息和认知。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1950504. doi: 10.1080/21645515.2021.1950504. Epub 2021 Jul 30.

本文引用的文献

1
A global survey of potential acceptance of a COVID-19 vaccine.一项针对 COVID-19 疫苗潜在接受度的全球调查。
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.
3
The COVID-19 social media infodemic.新冠病毒肺炎疫情相关社交媒体信息疫情。
Sci Rep. 2020 Oct 6;10(1):16598. doi: 10.1038/s41598-020-73510-5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验